{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:19:57Z","timestamp":1792153197810,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["71569"],"award-info":[{"award-number":["71569"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.TBZMED.REC.1402.349"],"award-info":[{"award-number":["IR.TBZMED.REC.1402.349"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jocn.2024.110990","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T05:01:42Z","timestamp":1734411702000},"page":"110990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis; a systematic review"],"prefix":"10.1016","volume":"132","author":[{"given":"Sara","family":"Daneshvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinush","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrab","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Golshaniniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Frounchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Seifimansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0109","authenticated-orcid":false,"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0005","first-page":"1","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","article-title":"Cognition in multiple sclerosis: State of the field and priorities for the future","volume":"90","author":"Sumowski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.110990_b0015","doi-asserted-by":"crossref","unstructured":"Mac\u00edas Islas M, Ciampi E. Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. Biomedicines. 2019;7(1);10.3390\/biomedicines7010022.","DOI":"10.3390\/biomedicines7010022"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s41983-022-00485-7","article-title":"Predominant domains and associated demographic and clinical characteristics in multiple sclerosis-related cognitive impairment in mildly disabled patients","volume":"58","author":"Talebi","year":"2022","journal-title":"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"10.1016\/j.jocn.2024.110990_b0025","article-title":"The Prevalence of Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-analysis","author":"Wu","year":"2024","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.jocn.2024.110990_b0030","doi-asserted-by":"crossref","unstructured":"Baierle M, Nascimento SN, Moro AM, Brucker N, Freitas F, Gauer B, et al. Relationship between inflammation and oxidative stress and cognitive decline in the institutionalized elderly. Oxidative medicine and cellular longevity. 2015;2015:804198;10.1155\/2015\/804198.","DOI":"10.1155\/2015\/804198"},{"issue":"5","key":"10.1016\/j.jocn.2024.110990_b0035","article-title":"The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease","volume":"6","author":"Budni","year":"2015","journal-title":"Aging Dis"},{"key":"10.1016\/j.jocn.2024.110990_b0040","doi-asserted-by":"crossref","unstructured":"Chen L, Liu B. Relationships between Stress Granules, Oxidative Stress, and Neurodegenerative Diseases. Oxidative medicine and cellular longevity. 2017;2017:1809592;10.1155\/2017\/1809592.","DOI":"10.1155\/2017\/1809592"},{"issue":"2","key":"10.1016\/j.jocn.2024.110990_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-9120(02)00287-4","article-title":"Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval","volume":"35","author":"Delibas","year":"2002","journal-title":"Clin Biochem"},{"issue":"104966","key":"10.1016\/j.jocn.2024.110990_b0050","article-title":"Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis","volume":"79","author":"Bergmann","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.jocn.2024.110990_b0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol"},{"issue":"103707","key":"10.1016\/j.jocn.2024.110990_b0060","article-title":"Reduced cognitive function contributes to economic burden of multiple sclerosis","volume":"60","author":"Maltby","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.jocn.2024.110990_b0065","first-page":"115","article-title":"Lucchinetti CJTimm","volume":"7","author":"Lassmann","year":"2001","journal-title":"Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0070","article-title":"Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects","volume":"11","author":"Ashtari","year":"2019","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"2","key":"10.1016\/j.jocn.2024.110990_b0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcma.2015.08.010","article-title":"Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?","volume":"79","author":"Guzel","year":"2016","journal-title":"J Chin Med Assoc"},{"issue":"708659","key":"10.1016\/j.jocn.2024.110990_b0080","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jocn.2024.110990_b0085","first-page":"823","article-title":"Cheng YJFin","volume":"14","author":"Zhang","year":"2020","journal-title":"Oxidative stress marker aberrations in multiple sclerosis: A meta-analysis study"},{"issue":"1213448","key":"10.1016\/j.jocn.2024.110990_b0090","article-title":"Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders","volume":"14","author":"Gonzalez","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11481-023-10059-w","article-title":"Inflammatory Cytokines Associated with Multiple Sclerosis Directly Induce Alterations of Neuronal Cytoarchitecture in Human Neurons","volume":"18","author":"Meyer-Arndt","year":"2023","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.jocn.2024.110990_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073995","article-title":"Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications","author":"Giri","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0105","first-page":"10","article-title":"Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review","volume":"53","author":"Park","year":"2020","journal-title":"BMBRep"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease","volume":"11","author":"Lyra","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jocn.2024.110990_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-023-00476-2","article-title":"Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD","author":"Lerche","year":"2023","journal-title":"npj Parkinson's Dis"},{"issue":"102478","key":"10.1016\/j.jocn.2024.110990_b0125","article-title":"Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis","volume":"46","author":"Motavalli","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jocn.2024.110990_b0130","unstructured":"Aromataris E MZE. JBI Manual for Evidence Synthesis. Available from https:\/\/synthesismanualjbiglobal https:\/\/doiorg\/1046658\/JBIMES-20-01. 2020."},{"issue":"71","key":"10.1016\/j.jocn.2024.110990_b0135","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2024.110990_b0140","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Chapter 7: Systematic Reviews of Etiology and Risk.10.46658\/JBIMES-20-082020."},{"key":"10.1016\/j.jocn.2024.110990_b0145","article-title":"Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability","volume":"25;10.1016\/j.nicl.2020.102177","author":"Silemek","year":"2020","journal-title":"Neuroimage-Clinical"},{"key":"10.1016\/j.jocn.2024.110990_b0150","article-title":"Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study","volume":"12;10.3389\/fneur.2021.678735","author":"Giedraitiene","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000080146","article-title":"The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis","volume":"11","author":"Haase","year":"2004","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2024.110990_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2012.07.044","article-title":"Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients","volume":"321","author":"Kalinowska-\u0141yszczarz","year":"2012","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0165","article-title":"Autoantibodies to myelin basic protein and histone h1 as immune biomarkers of neuropsychological disorders in patients with multiple sclerosis. Ukr","volume":"92","author":"Kyryliuk","year":"2020","journal-title":"Biochem J"},{"issue":"66\u201372","key":"10.1016\/j.jocn.2024.110990_b0170","article-title":"Can fibrinolytic system components explain cognitive impairment in multiple sclerosis?","volume":"382","author":"P\u00e9rez-Mart\u00edn","year":"2017","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jocn.2024.110990_b0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1756285608101379","article-title":"Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing\u2014remitting multiple sclerosis: 2-year results from the COGIMUS study","volume":"2","author":"Patti","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0180","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s10072-020-04847-y","article-title":"Impact of chemerin, lipid profile, and insulin resistance on disease parameters in patients with multiple sclerosis","volume":"42","author":"Koskderelioglu","year":"2021","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.jocn.2024.110990_b0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/NRE-220001","article-title":"Fatigue, cognition and inflammatory biomarkers changes in response to computer-based cognitive training in multiple sclerosis patients: A randomized controlled trial","volume":"51","author":"Moustafaa","year":"2022","journal-title":"NeuroRehabilitation"},{"issue":"1\u20137","key":"10.1016\/j.jocn.2024.110990_b0190","article-title":"Fatigue in Patients with Multiple Sclerosis: Is It Related to Pro- and Anti-Inflammatory Cytokines?","volume":"2015","author":"Malekzadeh","year":"2015","journal-title":"Dis Markers"},{"issue":"4","key":"10.1016\/j.jocn.2024.110990_b0195","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jnr.25163","article-title":"Neurocognitive impairment in multiple sclerosis and its association with thiol-disulfide homeostasis and ischemia-modified albumin","volume":"101","author":"Demirdogen","year":"2023","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jocn.2024.110990_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102621","article-title":"Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients","author":"El-Salem","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.jocn.2024.110990_b0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/1110-1083.183406","article-title":"Primary fatigue contributes to cognitive dysfunction in patients with multiple sclerosis","volume":"53","author":"El-Tamawy","year":"2016","journal-title":"Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","article-title":"Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?","volume":"77","author":"Heesen","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.jocn.2024.110990_b0215","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbi.2010.05.006","article-title":"Correlates of cognitive dysfunction in multiple sclerosis","volume":"24","author":"Heesen","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"103432","key":"10.1016\/j.jocn.2024.110990_b0220","article-title":"Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients","volume":"57","author":"Naseri","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.jocn.2024.110990_b0225","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/jnr.22276","article-title":"Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients","volume":"88","author":"Patanella","year":"2010","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0230","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","article-title":"The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients","volume":"42","author":"Talebi","year":"2021","journal-title":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"3","key":"10.1016\/j.jocn.2024.110990_b0235","first-page":"411","volume":"44","author":"\u015een","year":"2021","journal-title":"Cytokine\u2013chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement"},{"issue":"3), 10(1080\/01616412","key":"10.1016\/j.jocn.2024.110990_b0240","article-title":"Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis","volume":"40","author":"Trenova","year":"2018","journal-title":"Neurol Res"},{"key":"10.1016\/j.jocn.2024.110990_b0245","doi-asserted-by":"crossref","unstructured":"Talebi M, Majdi A, Kamari F, Sadigh-Eteghad S. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis. Multiple sclerosis and related disorders. 2020;43:102172;10.1016\/j.msard.2020.102172.","DOI":"10.1016\/j.msard.2020.102172"},{"issue":"105645","key":"10.1016\/j.jocn.2024.110990_b0250","article-title":"Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis","volume":"87","author":"Espiritu","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0255","first-page":"26","article-title":"A comprehensive review of attention tests: can we assess what we exactly do not understand? The Egyptian Journal of Neurology","volume":"59","author":"Nasiri","year":"2023","journal-title":"Psychiatry and Neurosurgery"},{"issue":"12","key":"10.1016\/j.jocn.2024.110990_b0260","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1007\/s10072-021-05165-7","article-title":"Cognitive impairment in multiple sclerosis: diagnosis and monitoring","volume":"42","author":"Meca-Lallana","year":"2021","journal-title":"Neurol Sci"},{"issue":"11","key":"10.1016\/j.jocn.2024.110990_b0265","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/1352458514533400","article-title":"Glutathione in multiple sclerosis: more than just an antioxidant?","volume":"20","author":"Carvalho","year":"2014","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"8","key":"10.1016\/j.jocn.2024.110990_b0270","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/1352458517711568","article-title":"In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis","volume":"24","author":"Choi","year":"2018","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"1","key":"10.1016\/j.jocn.2024.110990_b0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-017-1026-z","article-title":"Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study","volume":"15","author":"Hajjar","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jocn.2024.110990_b0280","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11011-022-01016-2","article-title":"The relationship between uric acid and brain health from observational studies","volume":"37","author":"Tang","year":"2022","journal-title":"Metab Brain Dis"},{"issue":"828476","key":"10.1016\/j.jocn.2024.110990_b0285","article-title":"The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction. Front","volume":"13","author":"Mijailovic","year":"2022","journal-title":"Psychiatry"},{"issue":"22","key":"10.1016\/j.jocn.2024.110990_b0290","doi-asserted-by":"crossref","first-page":"e2373","DOI":"10.1212\/WNL.0000000000009522","article-title":"Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis","volume":"94","author":"Landmeyer","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.110990_b0295","doi-asserted-by":"crossref","unstructured":"Thelen JM, Lynch SG, Bruce AS, Hancock LM, Bruce JMJJoPR. Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance. 2014;76(5):400-4.","DOI":"10.1016\/j.jpsychores.2014.02.013"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824005290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824005290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:25:19Z","timestamp":1778574319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824005290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"alternative-id":["S0967586824005290"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110990","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis; a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110990"}}